Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/13/9/1378/418010/mdf299.pdf
Reference33 articles.
1. The effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28896 women;Early Breast Cancer Trialists’ Collaborative Group;N Engl J Med,1988
2. The importance of histologic grade in long-term prognosis of breast cancer. A study of 1010 patients, uniformly treated at the Institut Gustave-Roussy;Contesso;J Clin Oncol,1987
3. Tamoxifen adjuvant treatment duration in early breast cancer: Initial results of a randomized study comparing short-term treatment with long-term treatment;Delozier;J Clin Oncol,2000
4. Competing risks determining event-free survival in early breast cancer;Arriagada;Br J Cancer,1992
5. Worldwide Evidence 1985–1990;Early Breast Cancer Trialists’ Collaborative Group. Treatment of Early Breast Cancer, Volume 1,1990
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis;Journal of Breast Cancer;2017
2. Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer;Oncology Letters;2016-02-17
3. Eribulin mesylate in heavily pretreated metastatic breast cancer patients: current practice in an Italian community hospital;Future Oncology;2014-02
4. Randomized Controlled Trials in Surgical Oncology:;Surgical Oncology Clinics of North America;2012-07
5. Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer;American Journal of Health-System Pharmacy;2012-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3